Gabelli Funds LLC Purchases 2,350 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Gabelli Funds LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 2.9% during the third quarter, Holdings Channel.com reports. The institutional investor owned 83,720 shares of the company’s stock after purchasing an additional 2,350 shares during the period. Gabelli Funds LLC’s holdings in HCA Healthcare were worth $20,593,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in HCA. Blueshift Asset Management LLC acquired a new position in HCA Healthcare during the third quarter worth approximately $647,000. Atria Wealth Solutions Inc. lifted its stake in shares of HCA Healthcare by 21.2% during the 3rd quarter. Atria Wealth Solutions Inc. now owns 1,678 shares of the company’s stock worth $413,000 after buying an additional 293 shares during the last quarter. Spire Wealth Management increased its stake in shares of HCA Healthcare by 485.1% during the third quarter. Spire Wealth Management now owns 2,399 shares of the company’s stock worth $590,000 after purchasing an additional 1,989 shares during the period. Banque Cantonale Vaudoise increased its position in HCA Healthcare by 1.7% during the 3rd quarter. Banque Cantonale Vaudoise now owns 11,150 shares of the company’s stock worth $2,742,000 after buying an additional 191 shares during the period. Finally, PGGM Investments grew its stake in shares of HCA Healthcare by 2.7% in the third quarter. PGGM Investments now owns 40,555 shares of the company’s stock valued at $9,976,000 after acquiring an additional 1,051 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In related news, EVP Michael S. Cuffe sold 3,200 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $306.79, for a total transaction of $981,728.00. Following the transaction, the executive vice president now directly owns 24,929 shares of the company’s stock, valued at approximately $7,647,967.91. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,200 shares of the business’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $306.79, for a total transaction of $981,728.00. Following the completion of the sale, the executive vice president now owns 24,929 shares in the company, valued at approximately $7,647,967.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 3,861 shares of the business’s stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the sale, the senior vice president now directly owns 15,899 shares of the company’s stock, valued at $4,880,993. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of a number of analyst reports. Sanford C. Bernstein lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating and increased their target price for the stock from $277.00 to $301.00 in a research report on Thursday, January 4th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, November 1st. Wells Fargo & Company decreased their target price on HCA Healthcare from $267.00 to $254.00 and set an “equal weight” rating on the stock in a research report on Thursday, October 26th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $315.00 price target on shares of HCA Healthcare in a report on Friday, January 19th. Finally, JPMorgan Chase & Co. lowered their price target on shares of HCA Healthcare from $313.00 to $265.00 and set a “neutral” rating for the company in a report on Friday, November 17th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $304.26.

Get Our Latest Research Report on HCA

HCA Healthcare Stock Up 0.1 %

Shares of NYSE HCA opened at $310.87 on Tuesday. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $314.82. The company’s 50 day moving average price is $274.85 and its 200-day moving average price is $262.23. The company has a market capitalization of $83.21 billion, a P/E ratio of 16.37, a price-to-earnings-growth ratio of 1.56 and a beta of 1.65. The company has a debt-to-equity ratio of 35.07, a quick ratio of 1.02 and a current ratio of 1.18.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Tuesday, January 30th. The company reported $5.90 earnings per share for the quarter, topping the consensus estimate of $5.05 by $0.85. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The firm had revenue of $17.30 billion during the quarter, compared to analyst estimates of $16.51 billion. During the same period last year, the company posted $4.64 EPS. The business’s quarterly revenue was up 11.7% on a year-over-year basis. Equities analysts forecast that HCA Healthcare, Inc. will post 20.38 earnings per share for the current year.

HCA Healthcare announced that its board has initiated a stock buyback program on Tuesday, January 30th that permits the company to repurchase $6.00 billion in shares. This repurchase authorization permits the company to buy up to 7.4% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Investors of record on Friday, March 15th will be paid a dividend of $0.66 per share. The ex-dividend date is Thursday, March 14th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.60. This represents a $2.64 annualized dividend and a yield of 0.85%. HCA Healthcare’s dividend payout ratio is currently 13.91%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.